Pediatric ulcerative colitis: current treatment approaches including role of infliximab

References

• HyamsJSInflammatory bowel diseasePediatr Rev200526931432016140873
   PubMed Web of Science ®Google Scholar
• CuffariCInflammatory bowel disease in children: a pediatrician’s perspectiveMinerva Pediatr200658213915716835574
   PubMedGoogle Scholar
• SawczenkoASandhuBKPresenting features of inflammatory bowel disease in Great Britain and IrelandArch Dis Child20038811995100014612366
   PubMed Web of Science ®Google Scholar
• HyamsJDavisPLererTClinical outcome of ulcerative proctitis in childrenJ Pediatr Gastroenterol Nutr19972521491529252900
   PubMed Web of Science ®Google Scholar
• UchidaKArakiTToiyamaYPreoperative steroid-related complications in Japanese pediatric patients with ulcerative colitisDis Colon Rectum2006491747916283565
   PubMed Web of Science ®Google Scholar
• CarvalhoRHyamsJSDiagnosis and management of inflammatory bowel disease in childrenSemin Pediatr Surg200716316417117602971
   PubMedGoogle Scholar
• GreiferMKMarkowitzJFUpdate in the treatment of paediatric ulcerative colitisExpert Opin Pharmacother20067141907191817020417
   PubMed Web of Science ®Google Scholar
• DevlinSMPanaccioneREvolving inflammatory bowel disease treatment paradigms: top-down versus step-upGastroenterol Clin North Am200938457759419913203
   PubMed Web of Science ®Google Scholar
• QuirosJAHeymanMBPohlJFSafety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind studyJ Pediatr Gastroenterol Nutr200949557157919633577
   PubMed Web of Science ®Google Scholar
• ToliaVMassoudNKlotzUOral 5-aminosalicyclic acid in children with colonic chronic inflammatory bowel disease: clinical and pharmacokinetic experienceJ Pediatr Gastroenterol Nutr1989833333382565380
   PubMed Web of Science ®Google Scholar
• D’AgataIDVanounouTSeidmanEMesalamine in pediatric inflammatory bowel disease: a 10–year experienceInflamm Bowel Dis199624229235
   PubMed Web of Science ®Google Scholar
• HeymanMBKierkusJSpenardJShbakloHGiguereMEfficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescentsInflamm Bowel Dis201016111931193920848454
   PubMed Web of Science ®Google Scholar
• HyamsJMarkowitzJLererTThe natural history of corticosteroid therapy for ulcerative colitis in childrenClin Gastroenterol Hepatol2006491118112316820327
   PubMed Web of Science ®Google Scholar
• TungJLoftusEVJrFreeseDKA population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn’s disease and ulcerative colitisInflamm Bowel Dis200612121093110017119382
   PubMed Web of Science ®Google Scholar
• Oliva-HemkerMEscherJCMooreDRefractory inflammatory bowel disease in childrenJ Pediatr Gastroenterol Nutr200847226627218664886
   PubMed Web of Science ®Google Scholar
• HyamsJSLererTMackDOutcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry studyAm J Gastroenterol2011106598198721224840
   PubMed Web of Science ®Google Scholar
• KirschnerBSSafety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel diseaseGastroenterology199811548138219753482
   PubMed Web of Science ®Google Scholar
• DubinskyMCAzathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safetyClin Gastroenterol Hepatol20042973174315354273
   PubMed Web of Science ®Google Scholar
• KandielAFraserAGKorelitzBIBrensingerCLewisJDIncreased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurineGut20055481121112516009685
   PubMed Web of Science ®Google Scholar
• BanerjeeSBishopWPEvolution of thiopurine use in pediatric inflammatory bowel disease in an academic centerJ Pediatr Gastroenterol Nutr200643332433016954954
   PubMed Web of Science ®Google Scholar
• TurnerDTravisSPGriffithsAMConsensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHANAm J Gastroenterol2011106457458821224839
   PubMed Web of Science ®Google Scholar
• TreemWRCohenJDavisPMJustinichCJHyamsJSCyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgeryDis Colon Rectum19953854744797736877
   PubMed Web of Science ®Google Scholar
• CastroMPapadatouBCeriatiERole of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitisLangenbecks Arch Surg2007392216116416909296
   PubMed Web of Science ®Google Scholar
• WatsonSPensabeneLMitchellPBousvarosAOutcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitisInflamm Bowel Dis2011171222920722055
   PubMed Web of Science ®Google Scholar
• KhanKJUllmanTAFordACAntibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysisAm J Gastroenterol2011106466167321407187
   PubMed Web of Science ®Google Scholar
• AlexanderFComplications of ileal pouch anal anastomosisSemin Pediatr Surg200716320020417602976
   PubMedGoogle Scholar
• SoodAMidhaVMakhariaGKThe probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitisClin Gastroenterol Hepatol20097111202120919631292
   PubMed Web of Science ®Google Scholar
• TursiABrandimarteGPapaATreatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled studyAm J Gastroenterol2010105102218222720517305
   PubMed Web of Science ®Google Scholar
• MatthesHKrummenerlTGienschMWolffCSchulzeJClinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)BMC Complement Altern Med2010101320398311
   PubMed Web of Science ®Google Scholar
• FujimoriSGudisKMitsuiKA randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitisNutrition200925552052519201576
   PubMed Web of Science ®Google Scholar
• MieleEPascarellaFGiannettiEQuagliettaLBaldassanoRNStaianoAEffect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitisAm J Gastroenterol2009104243744319174792
   PubMed Web of Science ®Google Scholar
• VeresGBaldassanoRNMamulaPInfliximab therapy in children and adolescents with inflammatory bowel diseaseDrugs200767121703172317683171
   PubMed Web of Science ®Google Scholar
• LawsonMMThomasAGAkobengAKTumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitisCochrane Database Syst Rev20063CD00511216856078
   PubMedGoogle Scholar
• RutgeertsPSandbornWJFeaganBGInfliximab for induction and maintenance therapy for ulcerative colitisN Engl J Med2005353232462247616339095
   PubMed Web of Science ®Google Scholar
• MamulaPMarkowitzJEBrownKAHurdLBPiccoliDABaldassanoRNInfliximab as a novel therapy for pediatric ulcerative colitisJ Pediatr Gastroenterol Nutr200234330731111964959
   PubMed Web of Science ®Google Scholar
• MamulaPMarkowitzJECohenLJvon AllmenDBaldassanoRNInfliximab in pediatric ulcerative colitis: two-year follow-upJ Pediatr Gastroenterol Nutr200438329830115076630
   PubMed Web of Science ®Google Scholar
• RussellGHKatzAJInfliximab is effective in acute but not chronic childhood ulcerative colitisJ Pediatr Gastroenterol Nutr200439216617015269622
   PubMed Web of Science ®Google Scholar
• EidelweinAPCuffariCAbadomVOliva-HemkerMInfliximab efficacy in pediatric ulcerative colitisInflamm Bowel Dis200511321321815735427
   PubMed Web of Science ®Google Scholar
• FanjiangGRussellGHKatzAJShort- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitisJ Pediatr Gastroenterol Nutr200744331231717325550
   PubMed Web of Science ®Google Scholar
• CucchiaraSRomeoEViolaFInfliximab for pediatric ulcerative colitis: a retrospective Italian multicenter studyDig Liver Dis200840Suppl 2S260S26418598998
   PubMedGoogle Scholar
• McGinnisJKMurrayKFInfliximab for ulcerative colitis in children and adolescentsJ Clin Gastroenterol200842887587918645529
   PubMed Web of Science ®Google Scholar
• TiemiJKomatiSSdepanianVLEffectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid useJ Pediatr Gastroenterol Nutr201050662863320386321
   PubMed Web of Science ®Google Scholar
• HyamsJDamarajuLBlankMInduction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitisClin Gastroenterol Hepatol201210439139922155755
   PubMed Web of Science ®Google Scholar
• HyamsJSLererTGriffithsAOutcome following infliximab therapy in children with ulcerative colitisAm J Gastroenterol201010561430143620104217
   PubMed Web of Science ®Google Scholar
• JacobsteinDAMarkowitzJEKirschnerBSPremedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortiumInflamm Bowel Dis200511544244615867583
   PubMed Web of Science ®Google Scholar
• MieleEMarkowitzJEMamulaPBaldassanoRNHuman antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximabJ Pediatr Gastroenterol Nutr200438550250815097438
   PubMed Web of Science ®Google Scholar
• RoshJRGrossTMamulaPGriffithsAHyamsJHepatosplenic T-cell lymphoma in adolescents and young adults with Crohn’s disease: a cautionary tale?Inflamm Bowel Dis20071381024103017480018
   PubMed Web of Science ®Google Scholar
• YanaiHHanauerSBAssessing response and loss of response to biological therapies in IBDAm J Gastroenterol2011106468569821427713
   PubMed Web of Science ®Google Scholar
• SandbornWJvan AsscheGReinischWAdalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitisGastroenterology2012142225726522062358
   PubMed Web of Science ®Google Scholar
• NoeJDPfefferkornMShort-term response to adalimumab in childhood inflammatory bowel diseaseInflamm Bowel Dis200814121683168718618629
   PubMed Web of Science ®Google Scholar
• BousvarosAUse of immunomodulators and biologic therapies in children with inflammatory bowel diseaseExpert Rev Clin Immunol20106465966620594138
   PubMed Web of Science ®Google Scholar
• BlonskiWBuchnerAMLichtensteinGRInflammatory bowel disease therapy: current state-of-the-artCurr Opin Gastroenterol201127434635721654383
   PubMed Web of Science ®Google Scholar
• TrueloveSCWittsLJCortisone in ulcerative colitis; final report on a therapeutic trialBr Med J1955249471041104813260656
   PubMed Web of Science ®Google Scholar
• TurnerDOtleyARMackDDevelopment, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter studyGastroenterology2007133242343217681163
   PubMed Web of Science ®Google Scholar
• TurnerDHyamsJMarkowitzJAppraisal of the pediatric ulcerative colitis activity index (PUCAI)Inflamm Bowel Dis20091581218122319161178
   PubMed Web of Science ®Google Scholar
• TurnerDMackDLeleikoNSevere pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of responseGastroenterology201013872282229120193683
   PubMed Web of Science ®Google Scholar